Hims & Hers Health, Inc. Class A
As of Oct 22, 2026, Hims & Hers Health is in Stage 3, the topping phase, now in week 7 (since Sep 9, 2026). It closed at $29.13, 40.3% below its 52-week high and above its 200-day average, which is falling.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, German… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is HIMS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
HIMS among Drug Manufacturers - Specialty & Generic54th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …54 | HIMS | Stage 3 · wk 7 | 28 | +2.6% |
Hims & Hers Health: quick answers
What stage is Hims & Hers Health in?
As of Oct 22, 2026, Hims & Hers Health (HIMS) is in Stage 3, the topping phase. It entered Stage 3 on Sep 9, 2026 and is in week 7. What the four stages mean
Is Hims & Hers Health in an uptrend?
Its uptrend has stalled. Hims & Hers Health is in Stage 3, the topping phase that follows an advance. It trades 7.2% above its 200-day average, which is falling.
How far is Hims & Hers Health from its 52-week high?
Hims & Hers Health closed at $29.13 on Oct 22, 2026, 40.3% below its 52-week high of $48.78. Its 52-week low is $14.52.
How has Hims & Hers Health performed over the past year?
As of Oct 22, 2026, Hims & Hers Health is down 41.0% over the past year and down 12.8% so far in 2026.
Which sector and industry is Hims & Hers Health in?
Hims & Hers Health is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.